ResearcherGhent University HospitalActive in the last 2 years
Kathleen Claes
Matched on ORCID iD 0000-0003-0841-7372; OpenAlex author ID A5028526077. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers
Papers 3
- EMT-associated bias in the Parsortix® system observed with pancreatic cancer cell lines. Last author DOI 10.1002/1878-0261.70066↗
- Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicente… Co-author DOI 10.1186/s12893-025-02938-1↗
- Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. Last author DOI 10.3390/cancers13174430↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nele Vandenbussche · 2 shared papers, 2025 · strength 0.45
- Karen Paula Geboes · 2 shared papers, 2021–2025 · strength 0.29
- Paper Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancr… DOI 10.1186/s12893-025-02938-1↗
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- L.F. Abreu de Carvalho · 1 shared paper, 2025 · strength 0.20
- Frederik Christiaan Berrevoet · 1 shared paper, 2025 · strength 0.20
- Filip Gryspeerdt · 1 shared paper, 2025 · strength 0.20
- Marta Kalousová · 1 shared paper, 2021 · strength 0.09
- Marianna Borecká · 1 shared paper, 2021 · strength 0.09
- Petra Kleiblová · 1 shared paper, 2021 · strength 0.09
- Michal Vočka · 1 shared paper, 2021 · strength 0.09
- Zdeněk Kleibl · 1 shared paper, 2021 · strength 0.09
- Greet Wieme · 1 shared paper, 2021 · strength 0.09
- Markéta Janatová · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.